DIABETES AND ENDOCRINOLOGY 2018
Diabetes is a group of metabolic diseases in which there
are high blood sugar levels over a prolonged period. Symptoms
of high blood sugar include frequent urination, increased
thirst, and increased hunger. If left untreated, diabetes can cause many
complications acute complications include diabetic
ketoacidosis and nonketotic hyperosmolar coma. Serious long-term
complications include cardiovascular disease, stroke, chronic
kidney failure, foot ulcers, and damage to the
eyes. Endocrinology is the study of the endocrine system in
the human body. It is also concerned with the integration of developmental
events proliferation, growth, and differentiation, and the psychological
WHY TO ATTEND?
This Conference will provide many opportunities to network and discuss science and technology about the advancements in treatments and management of Diabetes, ensure equity of opportunity, find new funding and research opportunities, and build collaborations and contacts with international colleagues to further continue one’s research at the global level.
Diabetes Congress 2018 provides two days robust discussions on methods and strategies related to symptoms and management of Diabetes as well as explore new ideas and concepts on a global scale and the topics include Diabetic complications, Diabetic Medicare and its advantages, Diabetic Nutrition, Diabetes and metabolism, Alternative treatment and therapies of Diabetes, Advancement in Diabetic Treatment and Diagnosis, Energy balance, obesity and Diabetes, Present scenario and risk factor of Diabetes, Diabetic Drug market, Clinical trials in Diabetes, Diabetic Education and Research.
- Endocrinology and Diabetes students, Scientists
- Medical Colleges
- Endocrinology and Diabetes Associations and Societies
- Business Entrepreneurs
- Training Institutes
Devices Companies Manufacturing Medical Diabetologists
- Business Professionals
- Academic Professionals
- Medical and Pharma Companies
- Medical Colleges and Hospitals
- Diabetes Societies and Association
Associations/ Research groups
- Harvard University
- University of Oxford
- University of Cambridge
- Johns Hopkins University
- Stanford University
- Yale University
- University of California, Los Angeles (UCLA)
- Imperial College London
- University of Melbourne
- Karolinska Institute
Allied Academics Cordially Welcomes all the participants
and contributors from worldwide to attend the International conference
on Diabetes and
We invite you to go to Upcoming Diabetes Congress and submit recommendations for oral and publication introductions, instructional exercises, workshops, corporate grandstands/demos and video introductions. Every proposition will be peer-looked into by for incorporation in the gathering system and procedures book which will be distributed in journal of diabetes and as an uncommon issue.
Session 1: Diabetes and Endocrinology
Endocrinology concentrates fundamentally on the endocrine organs or those organs that may bring about hormone changes in the body. These organs incorporate the pituitary, thyroid, adrenals, ovaries, testicles and pancreas and many more, each with their own particular occupations to do. These hormones are endocrine in nature and acts as very important signal transduction molecules which alters the constitutive and conditional expression of genes. The production and functional activity of these molecules is very sensitive in nature, any minute changes in the synthesis of these hormones can cause a set of serious metabolic or regulatory disorders. Diabetes is a sickness in which your body can't utilize and store glucose efficiently because of the hormonal deficiency of insulin.
Session 2: Recent Advances in Endocrinology
Endocrinology, the branch which primarily deals with the endocrine hormones, their production and function, is emerging rapidly due to better understanding of disease pathology and various new techniques that are making their way in the medical field. Development of recombinant techniques to produce synthetic hormones, cutting-edge diagnosis techniques, molecular investigation of disorders has significantly changed the scenario about endocrine diseases.
· Recombinant hormones
· Biochip- based diagnostic techniques.
· Molecular investigation and prognosis.
· Tissue regeneration of endocrine organs.
Session 3: Diabetes and its Consequences
Diabetes is a metabolic disorder which occurs due to imbalance between the demand and supply of the hormone insulin. The consequences of diabetes are simply far beyond our expectations with a new risk involved every day. Thus, if the hyperglycemia is not maintained, it can affect every organ in the body from tip to toe .With the correct treatment and recommended lifestyle changes, the onset of complications can be prevented (or) delayed. In addition to this there are the long term damages to our body which involve micro-vascular complications, cellulitis, Alzheimer’s disease, Angiopathy, diabetic ketoacidosis, hyperosmolar coma.
Session 4: Pathophysiology of Diabetes Type I and Type II
Diabetes is a metabolic disorder which occurs due to imbalance between the demand and supply of the hormone insulin. Pathophysiology of diabetes type I remarks the circumstances where an autoimmune disorder is generated which attacks and destroys the beta cells of the pancreas responsible for producing insulin which ultimately leads to complete insulin deficiency. Whereas in type II diabetes there is comparatively lesser deficiency of insulin than type I diabetes as the body is incapable of harvesting appropriate amount of insulin to overcome the demand. Gestational diabetes is one other type of diabetes caused when excessive counter-insulin hormones are produced by the body during pregnancy. This paves the way to a state of insulin resistance and high blood sugar in the mother further aggravated by faulty insulin receptors.
· Physiology of the endocrine pancreas
· Recent advances in genetics of diabetes
· Pathophysiology of diabetes type I
· Pathophysiology of diabetes type II
· Diabetic myelopathy
· Epidemiology of diabetes type I and II
Session 5: Genetics of Diabetes
Diabetes is a whole set of metabolic disorder characterized by persistent hyperglycaemia. Albeit a few significant components that have been distinguished for diabetes, the specific reason for onset of this disease are obscure. Certain HLA haplotypes are associated with a higher danger of acquiring type I diabetes, among which specific sets of HLA-DQA1, HLA-DQB1, and HLA-DRB1 brings about the most noteworthy risk of developing the disorder at a very early stage of life. In case of Diabetes type II, The disorder is said to be inherited in the family due to a set of disease susceptibility genes running down the generations which directly or indirectly regulate the expression of insulin.
Session 6: Advance Treatment for Diabetes
Currently, plenty of research is going on in the field of endocrinology-diabetes as it has become a common lifestyle and metabolic disorder of endocrine system around the world and causing huge number of deaths. The researchers are now emphasising on prognosis of diabetes along with its control by means of most effective advanced treatments. These advanced treatments include, development of insulin pumps, insulin injections, solid dosage forms, transplantations, surgeries, artificial pancreas, etc. Another objective is to make these new methods the most effective treatment which is affordable by the common population globally.
· Informatics in Medicine
· Insulin pumps and their market
· Inhalable insulin
· Regeneration of artificial pancreas
· Biosensors for prognosis of diabetes
· Telemedicine, Software and other Technologies
Session 7: Gestational Diabetes
Gestational diabetes develops in mothers during the period of pregnancy (gestation). Like other types of diabetes, gestational diabetes affects the mechanism of utilization of sugar (glucose) by body cells. High blood sugar levels in mother have adverse effects on pregnancy and upon the health of the infants. Besides these alarming effects of diabetes on pregnancy, expectant women can help control gestational diabetes by eating healthy foods, proper exercises and, if necessary, by taking medicines upon consultation with physicians.
Session 8: Diabetes Case Study and Research
The prime focus of the case studies in diabetes is to analyse the overall condition of the disorder with the help of research studies including animal models and human models. The integrated care for diabetes mellitus, in terms of the clinical outcomes and the evidence-based knowledge, is not sufficient enough. These case study protocols provide a description of the modern-day design and methodology required for implementation in the field of integrated care in diabetes. The aim of the proposed research is to investigate the mechanisms by which integrated care for diabetes can bring fruitful outcomes, keeping in mind the cost-efficacy of the method.
· Clinical research in diabetes.
· Case reports and analysis
· Integrated care methodology in diabetes
Session 9: Diabetic Nursing
Nursing management of diabetes includes effective treatment to normalize blood glucose and decrease complications using insulin replacement, balanced diet, and exercise. The function of nurse is to emphasise the importance of complying prescribed treatment program. Tailor- made teaching programs are devised focusing the patient’s needs, abilities, and developmental stage. Stress is given on the alternative effects of high blood glucose levels and control of long-term health.
Session 10: Medical Conditions Associated with Diabetes
Unregulated or undiagnosed diabetes is associated with the onset of various acute and chronic conditions in the body. These particularly involve obesity and lipid metabolism dysfunction, heart diseases, vision problems, nerve damage, kidney dysfunction and severe effects on bones. Increased blood sugar is the primary reason for all these complications. An active and healthy lifestyle is necessary to keep these ailments in check for years if a person is diagnosed with hyperglycaemia.
· Diabetic coma
· Diabetic neuropathy
· Ketoacidosis and its complications
· Diabetic retinopathy and glaucoma
· Diabetic nephropathy
· Diabetic osteopathy
· Obesity and lipid metabolism dysfunction
Session 11: Stem Cell Therapy in Diabetes
Stem cells used to cure type I diabetes is a replacement to conventional therapy which aims at swapping insulin-delivering cells from a healthy pancreas with those annihilated by diabetes in a diabetic patient. It is conceivable to treat Type 1 diabetes by transplanting confined islet cells, containing beta cells or even an entire pancreas into the patient from a contributor using the tissue engineering approach. Pancreatic stem cell or islets of Langerhans are a large groups of cells scattered all through the pancreas among which beta cells are capable of producing hormone insulin for body. Transplants can empower the body to recover control of glucose levels so administrating insulin is never required again.
· Artificial pancreas
· Stem cell therapy for Diabetes Type I
· Production of Beta cells
· Immune rejection
Session 12: Paediatric Endocrinology and Care
Paediatric Endocrinology is a medical subspecialty dealing with disorders of the endocrine glands in children, such as variations of physical growth and sexual development during puberty, diabetes and many more. The most common disease of this specialty is type I diabetes, which usually accounts for at least 50% of a typical clinical practice. The next most common problem is growth disorders, especially those amenable to growth hormone treatment. Paediatric endocrinologists are usually the primary physicians involved in the medical care of infants and children with intersex disorders. The specialty also deals with neurological disorders and other forms of developmental diseases in childhood.
Session 13: Neuroendocrinology
Neuroendocrinology is the study of the interaction between the nervous system and the endocrine system, including the biological features of the cells involved in it, i.e. Cytology, and how they communicate to bring about different body functions. The nervous and endocrine systems often act together in a process called neuroendocrine integration, to regulate the physiological processes of the human body. Neuroendocrinology arose from the recognition that the brain, especially the hypothalamus, controls secretion of pituitary gland hormones, and has subsequently expanded to investigate numerous interconnections of the endocrine and nervous systems.
Session 14: Clinical Endocrinology
Clinical endocrinology is the study of the endocrine system, its function, and its diseases or abnormalities, which could be multiple in nature, as related to patient care. The endocrine system can be defined as the set of organs in the body which release hormones that regulate many of the body’s functions, like the testes and ovaries, the pancreas, the pituitary gland, and the thyroid gland. Those who specialize in clinical endocrinology are highly trained physicians which analyse the overall effect of reduced or elevated hormonal levels on other organs and upon the signal transduction in body to devise appropriate therapies.
Session 15: Complementary and Alternative Medicines (CAM)
Complementary and alternative medicine is can be well-defined as a "cluster of varied therapeutic and health care arrangements, practices, and medicines that are not presently measured to be part of conventional medicine”. Complementary medicine is used with predictable therapy, whereas alternative medicine is used instead of conventional medicine. In CAM therapies, diabetes supplement given to the patients is widely popular. Although some of these therapies may be useful, others can be not so useful or clinically approved due to lack of substantial supporting research. Other than this, contrary reactions of many CAM therapies are not well known because patients with diabetes often combine them with clinical diabetic medications, and therefore, the efficacy of CAM medicines is not well- documented.
· Traditional medicine
· Herbal medicine
· Homeopathic treatments for diabetes.
Session 16: Reproductive Endocrinology and Infertility
Reproductive endocrinology is the study of male and female hormone system, including the activities of the hypothalamus, pituitary, ovaries and testes, right from the onset of puberty. A sub speciality of Obstetrics and Gynaecology specifically focuses on treating men and women with infertility or other related reproductive system issues which broadly includes hormonal imbalance, menstrual problems, infertility, miscarriage and sexual dysfunction.
· Poly-cystic ovarian disorder and insulin resistance
· Infertility in females
· Infertility in males
· Artificial Reproductive Techniques.
Session 17: Thyroid Disorders and Treatment
The metabolic rate of most of your body's organs is determined by thyroid. Normally, when thyroid hormone levels in the body are high, they will "switch off" the production of TSH, which in turn stops the thyroid from making more T4 and T3 .Problems occur when the thyroid gland becomes either underactive (hypothyroidism) or overactive (hyperthyroidism). Thyroid problems are more common in women than men. Cancer may also develop in the thyroid gland. The most common cause of hypothyroidism is Hashimoto's thyroiditis, an autoimmune condition where the body makes antibodies that destroy parts of the thyroid gland. Thyroid hormone production can be suppressed or halted completely by a variety of treatments available which are used for treating thyroid-related conditions.
- Hashimotos disease
- Management of Hyper & Hypothyroidism during Pregnancy
- Infertility, Miscarriage & Complications due to thyroid disorders
- Clinical prognosis and diagnosis of thyroid dysfunction
- Grave’s disease
- Anti-thyroid medication and Surgery
- Radioactive iodine treatment
“International conference on diabetes and Endocrinology” is
going to be held during October 15-16, 2108
at Tokyo, Japan
Diabetes congress 2018 conference gathers renowned scientists,
physicians, surgeons, young researchers, industrial delegates and talented
student communities in the field of diabetic medicine under a single roof where
networking and global partnering happens
for the acceleration of
The conference throws light on thought provoking topics and recent
research in the field of Diabetic Medications like, Type 1 Diabetes- Therapies
and treatments, Type 2 Diabetes- Therapies and treatments, Diabetic
Neuropathy-Treatment and Care, Management of Diabetic Heart Diseases,
Management of Diabetic Kidney Diseases, Clinical Diabetic Therapeutics &
Management, Islet Biology and Beta cell targeting, Computational Approaches for
Diabetes, and many more. The organizing committee is gearing up for an exciting
and informative conference
program including plenary lectures,
symposia, workshops on a variety of topics, poster presentations and various
programs for participants from all over the world. We invite you to join
Diabetes conference, where you are sure to have a meaningful experience with
scholars from around the world. All the Organizing Committee Members of the
Diabetes and Endocrinology 2018 International conference look forward to meet
you in Tokyo, Japan.
IMPORTANCE AND SCOPE:The prevalence of diabetes for all age-groups worldwide was estimated to
be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is
projected to rise from 171 million in 2000 to 366 million in 2030. The
prevalence of diabetes is higher in men than women, but there are more women
with diabetes than men. The urban population in developing countries is
projected to double between 2000 and 2030. The most important demographic
to diabetes prevalence across the world appears to be the
increase in the proportion of people >65 years of age. These findings
indicate that the “diabetes epidemic” will continue even if levels of obesity
remain constant. Given the increasing prevalence of obesity, it is likely that
these figures provide an underestimate of future diabetes prevalence.The number of people with diabetes has risen from 108 million in 1980 to
422 million in 2014. The global prevalence of diabetes* among adults over 18
years of age has risen from 4.7% in 1980 to 8.5% in 2014. In 2012, an estimated
1.5 million deaths were directly caused by diabetes and another 2.2 million
deaths were attributable to high blood glucose. Almost half of all deaths
attributable to high blood glucose occur before the age of 70 years1. WHO
projects that diabetes will be the 7th leading cause of death in 2030.Diabetes congress 2018 will feature the latest developments in
research, diagnosis and prevention and management of diabetes, new insulin
analogues and new technologies and devices for diabetic prevention,
and for treating obesity and many more. Not only will this innovative
conference enhance your practical and theoretical knowledge, it will
provide you with the unique opportunity to network with a wide range of
professionals in the field of diabetes technologies and treatments.
Based on diagnostic technologies, the tandem mass
spectrometry diagnostic technique was the largest segment of the global
endocrine testing market. The report also names immunoassays and
sensor technologies as rapidly growi
ng segments of the global endocrine testing
market. The report also cites findings published by Elsevier, Inc., which
examine the geriatric population above 65, of which 13.7%, have subclinical
hypothyroidism and 1.7% have hypothyroidism. Owing to the increasing
number of diabetics all over the world, the global endocrine testing market's
fastest growing testing segment is set to be the insulin test. The
ambulatory care centres segment is set to show the fastest growth
rat e within the report's forecast period. Top reasons for this segment's growth
are a speedier response rate and lower costs than the ones a patient would
otherwise incur. The home-based tests segment is also showing
promising development o pportunities and is predicted to gain a greater market
share in the near future. On the other hand, commercial laboratories will
continue to gain momentum in terms of revenue generation and consequently
invest more in further research. The report also cites information released by
the World Health Organization (WHO), in which the WHO states its prediction of
diabetes becoming the seventh leading cause of death in the world by 2030.
Nearly 80% deaths related to diabetes occur in middle-to-low-income homes, as
the disease is exacerbated by poor management.
WHY OSAKA?Osaka is the world’s 3rd safest city, second
largest metropolitan area in Japan
and among the largest in
the world with over 19 million inhabitants. Osaka has served as the capital of
Japan for centuries, been a port of entry for international exchange. In
more modern times, it has been a bastion of commerce and finance, and played a
major role in Japan’s industrial and economic development. Osaka has a plethora
of tourism resources to note a cityscape that has given it the name
of a Aqua metropolis. Easily accessible from within Japan and abroad
by multimodal transportation networks that feature Japan’s only 24-hour
airport in the Kansai International Airport, Osaka welcomes a round
210 million visitors every year for business, pleasure or what have you.
The Osaka-Umeda terminal is used by an average of around 2.5 million
people each day. “Grand Front Osaka” was opened in April 2013
as a new “town” at the gateway to Osaka. It has the greatest number of
manufacturing establishments in Japan with 18,229 companies. It is an area
where the artisan spirit lives on, with more than 60% of industrial production
in small and medium-sized enterprises that take the top share globally. It
forms an essential industrial base (supporting industry) for the development of
new growth sectors and cutting-edge products.
WHY JAPAN?Japan is the 3rd largest economy in the world.
It has a GDP 1.5 the
si ze of UK and per capita GDP 6 times that of
China; Japan re mains the high-tech power house economy of Asia. It
is the second highest spending worldwide on R&D, Japanese companies
remain amongst the most technologically valuable and advanced in the
world. Japan’s major growth driver is exports despite external
demand accounting for 16% of its total GDP.